MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

20 Oct 2022 Evaluate
The Top line for the quarter ended September 2022 of Rs. 0.68 millions up 88.89% from Rs. 0.36 millions.A slender decline of -26.63% was recorded to Rs. 1.35  millions from Rs. 1.84 millions in the corresponding previous quarter.The company reported a good operating profit of 2.28 millions compared to 2.02 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 0.68 0.36 88.89 2.76 0.59 367.80 3.65 69.91 -94.78
Other Income 4.32 4.27 1.17 8.73 8.05 8.45 19.19 14.66 30.90
PBIDT 2.28 2.02 12.87 5.16 3.03 70.30 10.25 23.12 -55.67
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.28 2.02 12.87 5.16 3.03 70.30 10.25 23.12 -55.67
Depreciation 0.23 0.18 27.78 0.46 0.32 43.75 0.92 0.58 58.62
PBT 2.05 1.84 11.41 4.70 2.71 73.43 9.33 22.54 -58.61
TAX 0.70 0.00 0.00 1.40 0.00 0.00 4.57 8.05 -43.23
Deferred Tax -0.30 0.00 0.00 0.40 0.00 0.00 0.22 4.48 -95.09
PAT 1.35 1.84 -26.63 3.30 2.71 21.77 4.76 14.49 -67.15
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 335.29 561.11 -40.24 186.96 513.56 -63.60 280.82 33.07 749.15
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..